Investigation of the association between the HindIII polymorphism of the LPL gene and the Taq1b polymorphism of the CETP gene with the risk of atherothrombotic stroke in the dwellers of Central Russia

Abstract


Aim. To investigate the association between LPL HindIII (rs320) and CETP Taq1b (rs708272) polymorphisms with the risk of atherothrombotic stroke (ATS) in the population of Central Russia. Materials and methods. A total of 832 DNA samples obtained from 417 patients with ATS and from 415 healthy individuals of the corresponding gender and age were investigated. The polymorphisms were genotyped by a real-time PCR assay using TaqMan probes. Results. The carriage of heterozygous LPL +495TG genotype was found to be associated with the lower risk of ATS (odds ratio (OR)=0.71; 95% CI: 0.53—0.94; p=0.02). A gender-stratified analysis showed that in the men the variant LPL +495TG genotype was associated with the increased risk of ATS (OR=2.06; 95% CI: 1.03—4.14; р=0.04) while the heterozygous +495GG genotype had a protective effect against the risk of stroke (OR=0.66; 95% CI: 0.45—0.97; р=0.04). Variance analysis established that this polymorphism was found to be associated with the increased prothrombin index in the men with ATS (p=0.01). Conclusion. This study was the first to reveal the association of the LPL HindIII (rs320) polymorphism with the increased prothrombin index and the risk of ATS in the Russian male population.

References

  1. Калашникова Л.А., Добрынина Л.А., Патрушева Н.Л. Мутации генов, сочетающиеся с тромбозами, при ишемическом инсульте у больных с первичным антифосфолипидным синдромом. Терапевтический архив. 2012;10:49-53.
  2. Кудайбергенова Н.Т., Молдоташев И.К., Алдашев А.А., Муханова А.К. Роль полиморфизма гена метилтетрагидрофолатредуктазы (MTHFR) в развитии ишемического инсульта у жителей Кыргызской Республики. Терапевтический архив. 2012;10:37-41.
  3. Shimo-Nakanishi Y, Urabe T, Hattori N, Watanabe Y, Nagao T, Yokochi M, Hamamoto M, Mizuno Y. Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese. Stroke. 2001;32(7):1481-1486.
  4. Fidani L, Hatzitolios AI, Goulas A, Savopoulos C, Basayannis C, Kotsis A. Cholesteryl ester transfer protein TaqI B and lipoprotein lipase Ser447Ter gene polymorphisms are not associated with ischaemic stroke in Greek patients. Neurosci Lett. 2005;384(1):102-105.
  5. Quarta G, Stanzione R, Evangelista A, Zanda B, Sciarretta S, Di Angelantonio E, Marchitti S, Di Murro D, Volpe M, Rubattu S. A protective role of a cholesteryl ester transfer protein gene variant towards ischaemic stroke in Sardinians. J Intern Med. 2007;262(5):555-561.
  6. Parfenov MG, Nikolaeva TY, Sudomoina MA, Fedorova SA, Guekht AB, Gusev EI, Favorova OO. Polymorphism of apolipoprotein E (APOE) and lipoprotein lipase (LPL) genes and ischaemic stroke in individuals of Yakut ethnicity. J Neurol Sci. 2007;255(1):42-49.
  7. Parfenov MG, Titov BV, Sudomoina MA, Martynov MIu, Favorov AV, Ochs MF, Gusev EI, Favorova OO. Genetic susceptibility to ischemic stroke in Russians. Mol Biol. 2009;43(5):873-880.
  8. Polonikov A, Vialykh E, Vasil’eva O, Bulgakova I, Bushueva O, Illig T, Solodilova M. Genetic variation in glutathione S-transferase genes and risk of nonfatal cerebral stroke in patients suffering from essential hypertension. J Mol Neurosci. 2012;47(3):511-513. doi: 10.1007/s12031-012-9764-y.
  9. Polonikov AV, Vialykh EK, Churnosov MI, Illig T, Freidin MB, Vasil’eva OV, Bushueva OY, Ryzhaeva VN, Bulgakova IV, Solodilova MA. The C718T polymorphism in the 3’-untranslated region of glutathione peroxidase-4 gene is a predictor of cerebral stroke in patients with essential hypertension. Hypertens Res. 2012;35(5):507-512. doi: 10.1038/hr.2011.213.
  10. Barter P J, Brewer HB, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23(2):160-167.
  11. Gudnason V, Kakko S, Nicaud V, Savolainen MJ, Kesäniemi YA, Tahvanainen E, Humphries S. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. Eur J Clin Invest. 1999;29(2):116-128.
  12. Duffy D, Rader DJ. Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport. Circulation. 2006;113(8):1140-1150.
  13. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res. 2002;43:1997-2006.
  14. Wittrup HH, Tybjærg-Hansen A, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation. 1999;99(22):2901-2907.
  15. Ahn YI, Kamboh MI, Hamman RF, Cole SA, Ferrell RE. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res. 1993;34(3):421-428.
  16. Huang P, Kostulas K, Huang WX, Crisby M, Kostulas V, Hillert J. Lipoprotein lipase gene polymorphisms in ischaemic stroke and carotid stenosis. Eur J Clin Invest. 1997;27(9):740-742.
  17. Полоников А.В., Ушачев Д.В., Шестаков А.М. Полиморфизм Gly460Trp гена α-аддуцина и предрасположенность к гипертонической болезни. Значение генно-средовых взаимодействий для возникновения заболевания в русской популяции. Терапевтический архив. 2009;3:31-35.
  18. Enquobahrie DA, Smith NL, Bis JC, Carty CL, Rice KM, Lumley T, Hindorff LA, Lemaitre RN, Williams MA, Siscovick DS, Heckbert SR, Psaty BM. Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and Toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke. Am J Cardiol. 2008;101(12):1683-1688. doi: 10.1016/j.amjcard.2008.02.052.
  19. Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis. 1989; 79(1):85-91.
  20. Rip J, Nierman MC, Ross CJ, Jukema JW, Hayden MR, Kastelein JJ, Stroes ES, Kuivenhoven JA. Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol. 2006;26(6):1236-1245.
  21. Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davis CE, Gotto AM Jr, Patsch W. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1993;13(8):1139-1158.
  22. Reilly SL, Ferrell RE, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III. Correlations and covariances. Am J Hum Genet. 1994;55(5):1001.
  23. Oscarsson J, Ottosson M, Vikman-Adolfsson K, Enerbäck S, Lithell H, Edén S. GH but not IGF-I or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats. JEndocrinol. 1999;160(2):247-255.
  24. Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, Adachi K, Morishige K, Ohmichi M, Matsuzawa Y, Murata Y. Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J Biol Chem. 2000;275(15):11404-11411.
  25. Mitropoulos KA, Miller GJ, Watts GF, Durrington PN. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency. Atherosclerosis. 1992;95(2):119-125.
  26. Miller GJ, Martin JC, Mitropoulos KA, Reeves BE, Thompson RL, Meade TW, Cooper JA, Cruickshank JK. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis. 1991;86(2):163-171.
  27. Taskinen MR, Kuusi T. 7 Enzymes involved in triglyceride hydrolysis. Baillieres Clin Endocrinol Metab. 1987;1(3):639-666.

Statistics

Views

Abstract - 88

Cited-By


Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.

Copyright (c) 2020 Bushueva O.Y., Stetskaya T.A., Korogodina T.V., Ivanov V.P., Polonikov A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies